Celsius Therapeutics
Celsius Therapeutics's Overview
Celsius Therapeutics is a biopharmaceutical company focused on dramatically changing the way medicines are discovered. By leveraging its proprietary SCOPE (Single Cell Observations for Precision Effect) platform, which integrates single-cell genomics, machine learning, and advanced experimental validation, Celsius aims to identify novel disease targets and develop precision therapeutics for autoimmune diseases and cancer. Their data-first approach seeks to unravel cellular and molecular disease complexities to deliver life-changing treatments to patients.
Where is Celsius Therapeutics's Headquarters?
HQ Function
Serves as the company's primary center for research and development, drug discovery using its SCOPE platform, and corporate operations.
Notable Features:
Located at 399 Binney Street, a modern life sciences building, featuring advanced laboratory facilities and collaborative workspaces designed for cutting-edge biotech research.
Work Culture:
A dynamic, science-driven environment fostering innovation and collaboration among multidisciplinary teams. Emphasis on data-first approaches and translating single-cell insights into therapies. The culture encourages rigorous scientific inquiry and a patient-focused mindset.
HQ Significance:
Its Cambridge location places Celsius Therapeutics at the heart of a world-leading biotechnology cluster, offering unparalleled access to premier talent, leading academic research institutions, and extensive partnership opportunities.
Values Reflected in HQ: The headquarters' focus on advanced research facilities and its strategic location reflect the company's commitment to scientific excellence, innovation, collaboration, and a pioneering spirit in drug discovery.
Location:
Celsius Therapeutics' operations are primarily centered in the United States, with its Cambridge, MA headquarters driving research, discovery, and development. While its physical R&D footprint is concentrated, the company may engage in global collaborations for clinical trials, research partnerships, and talent acquisition, aiming for a worldwide impact with its therapies.
Street Address:
399 Binney Street, Suite 200
City:
Cambridge
State/Province:
MA
Country:
USA
Celsius Therapeutics's Global Presence
Buying Intent Signals for Celsius Therapeutics
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
Executive Team of Celsius Therapeutics
As of April 2025, Celsius Therapeutics' leadership includes:
Investors of Celsius Therapeutics
Celsius Therapeutics has been backed by several prominent investors over the years, including:
Executive New Hires/Exits in the Last 12 Months
In the past 12 months (mid-2023 to mid-2024), Celsius Therapeutics significantly strengthened its leadership by appointing Tim Anderson as Chief Financial Officer. No major executive departures have been publicly announced during this period.
New Appointments:
Technology (Tech Stack) used by Celsius Therapeutics
Discover the tools Celsius Therapeutics uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Celsius Therapeutics Email Formats and Examples
Celsius Therapeutics likely utilizes common corporate email formats. Based on industry patterns, the most probable formats are [first initial][last name]@celsiustx.com or [first name].[last name]@celsiustx.com. Using these patterns increases the likelihood of successfully reaching an intended recipient.
Common formats include: flast@celsiustx.com (e.g., jdoe@celsiustx.com) and first.last@celsiustx.com (e.g., jane.doe@celsiustx.com)
Format
tkassum@celsiustx.com
Example
85%
Success rate
News and media
PR Newswire • June 11, 2024
Celsius Therapeutics Appoints Tim Anderson as Chief Financial Officer
Celsius Therapeutics announced the appointment of Tim Anderson as Chief Financial Officer. Mr. Anderson brings over 20 years of financial leadership experience in the biotechnology industry....more
Business Wire • April 10, 2024
Celsius Therapeutics Presents New Data from Its Clinical Program in IBD and Novel Target Discovery Efforts at Keystone Symposia
Celsius Therapeutics presented new data from its Phase 1b study of SIGLEC-10 antibody CEL383 in inflammatory bowel disease (IBD), along with insights from its SCOPE platform for novel target discovery, at the Keystone Symposia....more
Business Wire • November 7, 2023
Celsius Therapeutics Presented Preclinical Data from Its TREM1 Antibody Program for Inflammatory Disease at the American College of Rheumatology (ACR) Convergence 2023
Celsius Therapeutics shared preclinical data on its first-in-class TREM1 antibody program, highlighting its potential as a novel therapeutic approach for a range of inflammatory diseases, at the ACR Convergence 2023....more
Highperformr’s free tools for company research
Explore Employees by Region or Country
See where a company’s workforce is located, by country or region.
View Funding Details
View past and recent funding rounds with amounts and investors.
Understand Revenue Insights
Understand company revenue estimates and financial scale.
Track Active Job Openings
Track active roles and hiring trends to spot growth signals.
Review Product and Offerings
Discover what a company offers—products, platforms, and solutions.
Get SIC or NAICS Codes
Get the company’s official SIC and NAICS classifications.
Analyze Website Traffic Trends
Analyze visitor volume, engagement, and top traffic sources.
Discover Social Profiles and Engagement
Explore LinkedIn, Twitter, and other active social profiles.
Identify Top Competitors
Identify top competitors based on similar business traits.
Research and Discover Companies with Highperformr — Smarter, Faster
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
- Track intent signals to find buyers who are actively in-market
- Enrich contacts and companies instantly, no need to switch tools
- Automate workflows to stay ahead of every change
- Connect your CRM & tools for seamless data sync and activation
Thousands of companies, including Celsius Therapeutics, are just a search away.